Eliminating cervical cancer in the COVID-19 era

Field	Value	Language
dc.contributor.author	Ginsburg, Ophira	en
dc.contributor.author	Basu, Partha	en
dc.contributor.author	Kapambwe, Sharon	en
dc.contributor.author	Canfell, Karen	en
dc.date.accessioned	2021-06-02T04:55:07Z
dc.date.available	2021-06-02T04:55:07Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/2123/25247
dc.description.abstract	The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, poses a clear and present danger to the health and well-being of populations. Here we discuss its indirect impact on global cancer prevention and control efforts, particularly for cervical cancer. We suggest some comparisons between the COVID-19 pandemic and the human papillomavirus–induced cancer burden, as well as opportunities for translating pandemic-control strategies into effective cancer control.	en
dc.language.iso	en	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Eliminating cervical cancer in the COVID-19 era	en
dc.type	Article	en
dc.identifier.doi	10.1038/s43018-021-00178-9
dc.relation.other	Roche (United States)	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health	en

Associated file/s

There are no files associated with this item.